Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment

PLoS Neglected Tropical Diseases

Volumn 3, Issue 1, 2009, Pages

  Meyer, Thorsten ^a   Sekljic, Harald ^a   Fuchs, Stefan ^a   Bothe, Heiko ^a   Schollmeyer, Dieter ^b   Miculka, Christian ^a  

^a Intervet Innovation GmbH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTISCHISTOSOMAL AGENT;

ARTICLE; BITTER TASTE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; PATIENT COMPLIANCE; RACEMIC MIXTURE; SCHISTOSOMIASIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; CHILD; STEREOISOMERISM; TASTE;

CHILD; CRYSTALLOGRAPHY, X-RAY; HUMANS; MOLECULAR STRUCTURE; PRAZIQUANTEL; SCHISTOSOMIASIS; SCHISTOSOMICIDES; STEREOISOMERISM; TASTE;

EID: 65549111256     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000357     Document Type: Article

References (23)

1. Cioli D, Pica-Mattoccia L (2003) Praziquantel. Parasitol Res 90: S3-S9.
2. Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19(11): 509-15.
3. Liang Y-S, Coles GC, Doenhoff MJ, Southgate VR (2001) In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 31(11): 1227-35.
4. WHO Model Lists of Essential Medicines. Available http://www.who.int/ medicines/publications/essentialmedicines/en/ via the Internet. Accessed 1 Sept 2008.
5. WHO, Programmes and projects, Schistosomiasis Strategy. Available http://www.who.int/schistosomiasis/strategy/en/ via the Internet. Accessed 1 Sept 2008.
6. Montresor A, Crompton DWT, Gyorkos TW, Savioli L (2002) Helminth control in school-age children; A guide for managers of control programmes. Available http://www.who.int/wormcontrol/documents/en/itoviii.pdf via the Internet. Accessed 1 Sept 2008.
7. Talaat M, Dewolfe Miller F (1998) A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. Am J Trop Med Hyg 59(4): 546-50.
8. Bayer Inc (2004) Biltricide product monograph. Available www.bayerhealth.com/display.cfm?Object_ID=272&Article_ID=170 via the Internet. Accessed 1 Sept 2008.
9. Mattern C, Berger A (19/11/03) Process for masking the taste of substances by microencapsulation. EP1362583. Available http://v3.espacenet.com/publicationDetails/ biblio?KC=A1&date=20031119&NR=1362583A1&DB= EPODOC&locale=en_EP&CC=EP&FT=D via the Internet. Accessed 9 Dec 2008.
10. Bellinghausen R, Steinbeck M, Zank J, Weis M, Behrend O, et al. (28/06/ 07) Coated solid material, useful e.g. as powder-inhalant or oral dosage form, comprises a powdery solid material and a coating from a hydrophobic enveloping material, DE102005062270. Available http://v3.espacenet.com/publicationDetails/ biblio?KC=A1&date=20070628&NR=102005062270A1&DB= EPODOC&locale=en_EP&CC=DE&FT=D via the Internet. Accessed 9 Dec 2008.
11. Liu Y-H (2005) Levo-Praziquantel versus Praziquantel in experimental and clinical treatment of schistosomiases Japonica. Chin Med J 106(8): 593-596.
12. Liu Y-H, Qian M-X, Wang X-G, Jia J, Wang QN, Jiang YF, et al. (1986) Comparative efficacy of praziquantel and its optic isomers in experimental therapy of Schistosomiasis japonica in rabbits. Chin Med J 99(12): 935-940.
13. Xiao S-H, Catto BA (1989) Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni. J Infect Dis 159(3): 589-592.
14. Meier H, Blaschke G (2001) Investigation of Praziquantel metabolism in isolated rat hepatocytes. J Pharm Biomed Anal 26(3): 409-415.
15. WHO (2007) Global Plan to combat neglected tropical diseases 2008-2015. Available http://www.who.int/entity/neglected_diseases/ NTD%20Global%20plan_%20January%202007.pdf via the Internet. Accessed 1 Sept 2008.
16. Todd MH (2006) Enantioselective Synthesis of Praziquantel. The Synaptic Leap. Available http://www.thesynapticleap.org/schist/projects via the Internet. Accessed 1 Sept 2008.
17. TDR (2007) BL6 Business Plan 2008-2013. Available http://www.who.int/tdr/ about/strategy/pdf/bl6.pdf via the Internet. Accessed 1 Sept 2008.
18. Koenig WA (2002) Chirality in the natural world-odours and tastes, In: Chirality in Natural and Applied Science. Oxford: Blackwell Publishers. pp 261-284.
19. Wu M-H, Wei C-C, Xu Z-Y, Yuan H-C, Lian W-N, et al. (1991) Comparison of the Therapeutic Efficacy and Side Effects of a Single Dose of Levo-Praziquantel with Mixed Isomer Praziquantel in 278 Cases of Schistosomiasis Japonica. Am J Trop Med Hyg 45(3): 345-349.
20. Roszkowski P, Maurin JK, Czarnocki Z (2006) Enantioselective Synthesis of (R)-(-)-Praziquantel (PZQ). Tetrahedron Asymm 17: 1415-1419.
21. Blaschke G (1986) Chromatographic Resolution of Chiral Drugs on Polyamides and Cellulose Triacetate. J Liq Chromat 9(2&3): 341-368.
22. Directorate for the Quality of Medicines of the Council of Europe (2006) European Pharmacopoeia, Fifth Edition, Supplement 5.7. Strasbourg.
23. Bitnes J, Martens H, Ueland Ø, Martens M (2007) Longitudinal study of taste identification of sensory panellists: Effect of Ageing, Experience and Exposure. Food Qual Prefer 18: 230-241.